Cargando…
Commentary on Prevention a Possible Drug–Drug Interaction: Is Concurrent Administration of Orlistat and Pioglitazone Increase the Risk of Durg-Induced Hepatotoxicity?
BACKGROUND: Drug–drug interactions (DDIs) are an emerging threat to public health and are difficult to detect. To prevent DDIs and their burden, the possible DDIs should be kept in mind. We know that the obesity predisposes to the development of insulin resistance and type 2 diabetes. Therefore, com...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Medknow Publications & Media Pvt Ltd
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4362284/ https://www.ncbi.nlm.nih.gov/pubmed/25789148 http://dx.doi.org/10.4103/2008-7802.151825 |